From: Relationship between genome and epigenome - challenges and requirements for future research
Acronym | Project description | Website |
---|---|---|
ATLAS | Development of Laser-Based Technologies and Prototype Instruments for Genome-Wide Chromatin ImmunoPrecipitation Analyses | |
BLUEPRINT | A BLUEPRINT of haematopoietic Epigenomes | |
CANCERDIP | The use of Methylated DNA Immunoprecipitation MeDIP in cancer for better clinical management | |
CELLOMATIC | High Throughput Systematic Single Cell Genomics using Micro/Nano-Fluidic Chips for Extracting, Pre-analysing, Selecting and Preparing Sequence-ready DNA | |
CURELUNG | Epigenetic therapeutic strategies for improving lung cancer diagnosis | |
ELIXIR | European Life-Science Infrastructure | |
EPIFEMCARE | Epigenetics for Female Personalised Cancer Care | |
EPIGENESYS | Epigenetics towards systems biology | |
ESGI | European Sequencing and Genotyping Infrastructure | |
EUROBATS | Identifying biomarkers of ageing using whole transcriptome sequencing | |
GENCODYS | Genetic and Epigenetic Networks in Cognitive Dysfunction | |
GENICA | Genomic instability in cancer and pre-cancer | |
GEUVADIS | Genetic European Variation in Disease | |
IDEAL | Integrated research on developmental determinants of Aging and Longevity | |
MARK-AGE | European study to establish biomarkers for human aging | |
MEDALL | Mechanisms of the Development of ALLergy | |
MODHEP | An integrative genomic-epigenomic approach to liver cancer | |
NGS-PTL | Next Generation Sequencing platform for targeted Personalized Therapy of Leukemia | |
RADIANT | Rapid development and distribution of statistical tools for high-throughput sequencing data | |
READNA | REvolutionary Approaches and Devices for Nucleic Acid Analysis | |
SETTREND | Schistosoma epigenetics: targets, regulation, new drugs | |
SIROCCO | Silencing RNAs: organisers and coordinators of complexity in eukaryotic organisms | |
SWITCHBOX | Homeostatic mechanisms to facilitate maintenance of health from early life through to aging | |
International consortia | ||
IHEC | International Human Epigenome Consortium | |
Cost actions | ||
TD0905 Epigenetics from bench to bedside | ||
COST- FA1201– Epigenetics and periconception environment | ||
COST-BM– 1201 Developmental origins of chronic lung diseases | ||
COST- BM1102 Ciliates as model systems to study genome evolution, mechanisms of non-Mendelian inheritance, and their roles in environmental adaptation | ||
COST Action BM1106 ‘The Genes in Irritable Bowel Syndrome Research Network Europe (GENIEUR)’ | ||
COST-BM1007 – Mast cells and basophils – targets for innovative therapies | ||
BM1006 Next Generation Sequencing Data Analysis network (SeqAhead) | ||
BM0806 - Recent advances in histamine receptor H4R research | ||
BM0801 Translating Genomic and epigenetic Studies of MDS and AML (EUGESMA) |